Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.
Brizel DM, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier A, Eschwege F, Zhang J, Russell L, Oster W, Sauer R.
Brizel DM, et al. Among authors: strnad v.
J Clin Oncol. 2000 Oct 1;18(19):3339-45. doi: 10.1200/JCO.2000.18.19.3339.
J Clin Oncol. 2000.
PMID: 11013273
Clinical Trial.